[go: up one dir, main page]

FR2970178B1 - Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance - Google Patents

Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance

Info

Publication number
FR2970178B1
FR2970178B1 FR1100060A FR1100060A FR2970178B1 FR 2970178 B1 FR2970178 B1 FR 2970178B1 FR 1100060 A FR1100060 A FR 1100060A FR 1100060 A FR1100060 A FR 1100060A FR 2970178 B1 FR2970178 B1 FR 2970178B1
Authority
FR
France
Prior art keywords
promoters
better tolerance
level delivery
specific liver
liver level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1100060A
Other languages
English (en)
Other versions
FR2970178A1 (fr
Inventor
Liliane Therese Jacquot
Jacques Paul Djian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AURELIE DJIAN, FR
Deborah Anna Djian Fr
JOYCE AMELIE DJIAN, FR
Laurence Leruste Fr
Liliane Therese Jacquot Fr
Nicolas Djian Fr
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1100060A priority Critical patent/FR2970178B1/fr
Priority to PCT/FR2012/000008 priority patent/WO2012093227A1/fr
Publication of FR2970178A1 publication Critical patent/FR2970178A1/fr
Application granted granted Critical
Publication of FR2970178B1 publication Critical patent/FR2970178B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1100060A 2011-01-07 2011-01-07 Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance Expired - Fee Related FR2970178B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1100060A FR2970178B1 (fr) 2011-01-07 2011-01-07 Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance
PCT/FR2012/000008 WO2012093227A1 (fr) 2011-01-07 2012-01-06 Promédicaments pour une délivrance au niveau du foie d'une statine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1100060A FR2970178B1 (fr) 2011-01-07 2011-01-07 Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance

Publications (2)

Publication Number Publication Date
FR2970178A1 FR2970178A1 (fr) 2012-07-13
FR2970178B1 true FR2970178B1 (fr) 2014-06-20

Family

ID=43984138

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1100060A Expired - Fee Related FR2970178B1 (fr) 2011-01-07 2011-01-07 Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance

Country Status (2)

Country Link
FR (1) FR2970178B1 (fr)
WO (1) WO2012093227A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115025242B (zh) * 2022-05-19 2023-10-20 南开大学 一种他汀前药和他汀靶向递送系统及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204129D0 (en) * 2002-02-21 2002-04-10 Novartis Ag Process for the manufacture of organic compounds
SI1915349T1 (sl) * 2005-06-24 2016-05-31 Lek Pharmaceuticals D.D. Postopek za pripravo čistega amorfnega rosuvastatin kalcija
WO2008075165A1 (fr) * 2006-12-19 2008-06-26 Pfizer Products Inc. Nouveau procédé pour la synthèse de l'acide [r-(r*, r*)]-2-(4-fluorophényl)-bêta, delta-dihydroxy-5-(1-méthyléthyl)-3-phényl-4-[(phénylamino)carbonyl]-1h-pyrrole-1-heptanoïque ou d'un sel pharmaceutiquement acceptable de celui-ci
WO2009009152A1 (fr) * 2007-07-12 2009-01-15 Teva Pharmaceutical Industries Ltd. Intermédiaires de la rosuvastatine et leur préparation
KR100813666B1 (ko) * 2007-10-23 2008-03-14 (주)에이에스텍 콜레스테롤 합성 저해제로서 아토르바스타틴의 프로드럭

Also Published As

Publication number Publication date
FR2970178A1 (fr) 2012-07-13
WO2012093227A1 (fr) 2012-07-12

Similar Documents

Publication Publication Date Title
CY2023014I1 (el) Αντι il-36r αντισωματα
PL2717893T3 (pl) Kompozycje nanocząstek lipidowych i sposoby do dostarczania mRNA
DK2661266T3 (da) Kemosensoriske receptorligandbaserede terapier
DK2756080T3 (da) Multimeriske oligonukleotidforbindelser
EP2774321A4 (fr) Plateforme d'interopérabilité en nuage pour visioconférence
EP2762181A4 (fr) Pompe pour solution de perfusion
DK2791160T3 (da) Modificerede mrna-sammensætninger
DK2549029T3 (da) Platformsystem
EP2702828A4 (fr) Sachets interactifs pour micro-ondes
EP2548549A4 (fr) Composition pour émulsion
EP2708280A4 (fr) Microréacteur pour photoréactions
EP2752279A4 (fr) Camion malaxeur
EP2725011A4 (fr) Nouveau composé
EP2754444A4 (fr) Composition pour améliorer un paramètre du métabolisme in vivo
FI11374U1 (fi) Bensiinikoostumukset
EP2729134A4 (fr) Compositions et méthodes pour surmonter une résistance au tramadol
EP2683946A4 (fr) Pompe rotodynamique pour débit de sortie variable
EP2756506A4 (fr) Techniques pour bobines
EP2825758A4 (fr) Système de pompe pour réduction tms aoc
EP2786827A4 (fr) Composant lié
FR2970178B1 (fr) Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance
EP2638901A4 (fr) Agent pour induire un interféron endogène
FR2974579B1 (fr) Composition nettoyante liquide
EP2550955A4 (fr) Composition pour émulsion
DK2592267T3 (da) Doseringspumpe med anslagsdæmper

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

TQ Partial transmission of property

Owner name: LILIANE THERESE JACQUOT, FR

Effective date: 20150520

Owner name: NICOLAS DJIAN, FR

Effective date: 20150520

Owner name: JOYCE AMELIE DJIAN, FR

Effective date: 20150520

Owner name: AURELIE DJIAN, FR

Effective date: 20150520

Owner name: LAURENCE LERUSTE, FR

Effective date: 20150520

Owner name: DEBORAH ANNA DJIAN, FR

Effective date: 20150520

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20170929